CytoMed Therapeutics (GDTC) Accounts Payables (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Accounts Payables of $342478.0 for Q4 2025, down 28.31% sequentially from $477690.0 in Q2 2025, and up 3.3% YoY from $331550.7 in Q4 2024.
CytoMed Therapeutics (GDTC) Accounts Payables (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Accounts Payables for 5 years, with the latest figure at $342478.0 in Q4 2025.
- Quarterly Accounts Payables rose 3.3% year-over-year to $342478.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $342478.0 (up 3.3% YoY) and the FY2025 annual result came in at $345180.0, up 4.55% from the prior year.
- Accounts Payables fell to $342478.0 in Q4 2025 per GDTC's latest filing, from $477690.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $477690.0 in Q2 2025 and troughed at $161181.9 in Q4 2021.
- A 5-year average of $323078.9 and a median of $323881.9 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables surged 86.15% in 2022, then dropped 14.68% in 2024.
- Over 5 years, Accounts Payables stood at $161181.9 in 2021, then soared by 86.15% to $300040.6 in 2022, then advanced by 29.51% to $388585.0 in 2023, then decreased by 14.68% to $331550.7 in 2024, then rose by 3.3% to $342478.0 in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $342478.0, $477690.0, and $331550.7 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | CytoMed Therapeutics | 10.72 Mn | 9.11 Mn | - | 342,478.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 342,478.00 |
| Jun 30, 2025 | 477,690.00 |
| Dec 31, 2024 | 331,550.70 |
| Jun 30, 2024 | 316,213.00 |
| Dec 31, 2023 | 388,585.04 |
| Jun 30, 2023 | 266,892.00 |
| Dec 31, 2022 | 300,040.56 |
| Dec 31, 2021 | 161,181.94 |